2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

¡®¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©¡¯ °³ÃÖ

»ó¼³ üÇèºÎÅÍ »ê»ç Äܼ­Æ®, ¸í»çÃÊû¹ýȸ±îÁö¡¦ ½ÅÁß³âÃþ ¸ÂÃã ÇÁ·Î±×·¥
º¸ÇöÇà¿øÀ» ½ÇõÇÏ´Â Àü¹ýµµ·® ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç(ÁÖÁö °¡¼·½º´Ô)°¡ 8¿ù 1ÀϺÎÅÍ 10¿ù 31ÀϱîÁö 3°³¿ù°£ ¹®ÇÐÀ» ÅëÇÑ ¸¶À½ Ä¡À¯ ÇÁ·Î±×·¥ ‘Á¦3ȸ ¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©(ÁÖÃÖ ¹× ÁÖ°ü: ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç, ÈÄ¿ø: °æ±âµµ)’¸¦ ÁøÇàÇÑ´Ù°í 30ÀÏ ¹àÇû´Ù. °æ±âµµ ±¤¸í½Ã¿¡ À§Ä¡ÇÑ ±Ý°­Á¤»ç´Â ȸÁÖ½º´ÔÀ̽Šº®¾Ï(ÁöÈ«)½º´Ô°ú Àç°¡ºÒÀÚµéÀÇ ¿ø·ÂÀ¸·Î ºÒ±â 2535³â(1991³â) 1¿ù °³¿øÇÑ ½ÅÇà °øµ¿Ã¼´Ù. È£¹ý¹ýȸ ¹× ÀÏ¿ä¹ýȸ µî ´Ù¾çÇÑ Á¤±â¹ýȸ¸¦ ºñ·ÔÇØ ‘³» ¸¶À½ÀÇ Çູ¿©Çà(1¹Ú2ÀÏ Ã¼ÇèÇü)&rs ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¿ì¸®ÀºÇà, Á¤»ê¸®½ºÅ© ¾ø´Â ¾ÈÀüÇÑ Ç×°ø±Ç °áÁ¦¼­ºñ½º ±¸Ãà (2024-09-04)
¸ÂÃã ¿©Çà Ç÷§Æû ¿ä¸ð, ¡®¿©±Ç Á¤º¸ ½Ç½Ã°£ °ËÁõ¡¯ ¼­ºñ½º (2024-08-20)
Çö´ëÂ÷∙±â¾Æ ¹èÅ͸® ¾ÈÀü ÇÙ½É ±â¼ú °ø°³ (2024-08-17)
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-P... (2024-12-13)
United States, China, and United Kingdom Lead the Global AI ... (2024-12-07)
ÇÑÈ­±×·ì, ¿ì¼öÇù·Â»ç ÀÏÀÚ¸®¹Ú¶÷ȸ °³ÃÖ (2023-05-19)
Ga-Eul Debate Get-Together 2024 Successfully Concludes at Du... (2024-10-29)
¾×Ƽºê½Ã´Ï¾î°¡ ¼±È£ÇÏ´Â ¶ó¸é Á¦Á¶ ºê·£µå 1À§´Â ¡®³ó½É¡¯ (2024-06-06)
´ë¼¼ À¥¿¹´É ¡®Àü°úÀÚ¡¯, 14ÀϺÎÅÍ ¡®Á¾°­ÆÄƼ¡¯ ¿¬´Ù?! (2023-12-14)
Type One Energy and TVA Sign Agreement Focused on First Fusi... (2025-02-24)
KT&G »ó»ó½ºÅ¸Æ®¾÷Ä·ÇÁ 8±â, ±Û·Î¹úÆ®·¢ ÇÇε¥ÀÌ (2024-09-02)
NTT DATA, Inc. Appoints Sudhir Chaturvedi as Global Chief Gr... (2025-02-15)
»ç¾÷ÀÚµî·ÏÁõ¸¸ ÀÖÀ¸¸é ¸ÂÃã URL °áÁ¦ OK (2024-07-22)
ÀÌÅ»¸®¾Æ ÇÁ¸®¹Ì¾ö ¼¶À¯ Àü½Ãȸ¼­ Çѱ¹ ºê·£µå ¾Ë¸°´Ù (2024-07-10)
³ëÀÌÁî ĵ½½¸µ ºí·çÅõ½º ÇìµåÆù ¡®½ºÆäÀ̽º ¿ø¡¯ (2023-12-15)
HistoSonics Edison¢ç Histotripsy System Treats First Pancrea... (2024-12-26)
ÇÏ·ç ¸¸¿¡ ÀÌÇØÇÏ´Â ÀϺ» È­Àåǰ ÆÇ¸Å AtoZ (2024-12-05)
»ùÇ¥ ¡®2024 ¸í¹®Àå¼ö±â¾÷¡¯ ¼±Á¤ (2024-11-29)
ÁÖÂ÷¡¤Ä«Ç® ¼­ºñ½º ÆÄÅ·¹Ú, Àü·«Àû ÅõÀÚÀ¯Ä¡ ÃßÁø (2024-11-29)
·Ôµ¥Á¤¹ÐÈ­ÇÐ, ºÎÆÐ¹æÁö¡¤±Ô¹üÁؼö °æ¿µ½Ã½ºÅÛ ÀÎÁõ Ãëµæ (2024-09-27)
Çѱ¹¼öÀÚ¿ø°ø»ç, °ø±â¾÷ ÃÖÃÊ GGGI °ø·Î ǥâ ¼ö»ó (2024-08-31)
Àü±âÂ÷ º¸À¯ÀÚ-ºñº¸À¯ÀÚ, ¡®ÁÖÂ÷-ÃæÀü¡¯¿¡ ´ëÇÑ ÀÇ°ß ±Ø°ú ±Ø (2024-08-25)
Áß±¹ÀÌ ³²ºÏÅëÀÏÀÇ °É¸²µ¹.. ºñÈ£°¨µµ »ó½Â (2016-07-27)
ÀâÄÚ¸®¾Æ, PC ÅëÇÕ°Ë»ö UI¡¤UX °³Æí¡¦ ±¸Á÷ÀÚ ÆíÀÇ °­È­ (2024-08-04)
¸¸ 7¼¼ºÎÅÍ ½ÃÀÛÇÏ´Â ¸ð¹ÙÀÏ ±ÝÀ¶ ¼­ºñ½º ¡®Âɲ¿¹Ì¡¯ Ãâ½Ã (2023-11-12)
       [ÀÌÀü][1]....[489][490][491][492][493][494][495][496][497]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..